{"componentChunkName":"component---src-templates-chapter-level-1-chapter-level-1-tsx","path":"/topics/luts-in-men/references/","result":{"pageContext":{"chapter":{"id":"0b3152db-f873-5814-b35f-54711f247dff","slug":"references","fullItemName":"References","depth":1,"htmlHeader":"<!-- begin field 0dbd22f5-0622-41e8-9dd3-5d1757b638ea --><h1>References</h1><!-- end field 0dbd22f5-0622-41e8-9dd3-5d1757b638ea -->","summary":null,"htmlStringContent":"<!-- begin item 92c0d8e4-4f3b-4954-a26c-316da3acad16 --><!-- begin field e86ca9f6-b86b-44cc-a742-108eed866b57 --><ul class=\"bibliography\"><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    &#216;ster&#248; &#237; J&#225;kupsstovu, J. and&#160;Brodersen, J.                </span> (<span property=\"dcterms:issued\">2018</span>) <span property=\"dc:title\">Do men with lower urinary tract symptoms have an increased risk of advanced prostate cancer?</span> <em>BMJ</em> <strong><span rel=\"bibo:volume\">361</span></strong>.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    ABPI                </span> (<span property=\"dcterms:issued\">2016a</span>) <em><span property=\"dc:title\">SPC for Noqdirna 25 microgram oral lyophilisate</span></em>. <span property=\"bibo:Collection\">Electronic Medicines Compendium</span>. <span property=\"dc:publisher\">Datapharm Communications Ltd.</span> <span rel=\"bibo:Website\"><a href=\"https://www.medicines.org.uk/emc\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"17508c2c-827a-4049-a95a-ac080006079d\">https://www.medicines.org.uk/emc</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.medicines.org.uk/emc/medicine/32493\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"29a681c9-2887-48ac-9833-ac08000607ac\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    ABPI                </span> (<span property=\"dcterms:issued\">2016b</span>) <em><span property=\"dc:title\">SPC for Furosemide 40mg Tablets</span></em>. <span property=\"bibo:Collection\">Electronic Medicines Compendium</span>. <span property=\"dc:publisher\">Datapharm Communications Ltd.</span> <span rel=\"bibo:Website\"><a href=\"https://www.medicines.org.uk/emc\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"e109c5b3-48ea-46f7-80dd-ac08000a1c9d\">https://www.medicines.org.uk/emc</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.medicines.org.uk/emc/medicine/25736\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"fc99d215-129c-4142-b66c-ac08000a1cb0\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    ABPI                </span> (<span property=\"dcterms:issued\">2016c</span>) <em><span property=\"dc:title\">SPC for&#160;desmopressin acetate</span></em>. <span property=\"bibo:Collection\">Electronic Medicines Compendium</span>. <span property=\"dc:publisher\">Datapharm Communications Ltd.</span> <span rel=\"bibo:Website\"><a href=\"https://www.medicines.org.uk/emc\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"dcf429ee-2284-47ef-b096-ac070187cc10\">https://www.medicines.org.uk/emc</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.medicines.org.uk/emc/medicine/32498\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"6814217e-b60f-4057-ae49-ac070187cc23\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    ABPI                </span> (<span property=\"dcterms:issued\">2017a</span>) <em><span property=\"dc:title\">SPC for&#160;Xatral XL 10mg prolonged release tablets</span></em>. <span property=\"bibo:Collection\">Electronic Medicines Compendium</span>. <span property=\"dc:publisher\">Datapharm Communications Ltd.</span> <span rel=\"bibo:Website\"><a href=\"http://www.medicines.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"7d5df5a7-8c87-4c96-8cb0-ac08000a16d2\">http://www.medicines.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.medicines.org.uk/emc/product/1475/smpc\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"0d1f2fd9-45b8-4041-847c-ac08000a16f8\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    ABPI                </span> (<span property=\"dcterms:issued\">2017b</span>) <em><span property=\"dc:title\">SPC for&#160;Betmiga 25mg prolonged-release tablets</span></em>. <span property=\"bibo:Collection\">Electronic Medicines Compendium</span>. <span property=\"dc:publisher\">Datapharm Communications Ltd.</span> <span rel=\"bibo:Website\"><a href=\"https://www.medicines.org.uk/emc\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"b5ffeca4-e6f6-4ee8-b2e8-ac080001c4eb\">https://www.medicines.org.uk/emc</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.medicines.org.uk/emc/product/2977/smpc\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"686d4126-0cf4-4719-b20c-ac080001c4fb\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    ABPI                </span> (<span property=\"dcterms:issued\">2018a</span>) <em><span property=\"dc:title\">SPC for Tamsulosin Zentiva 400 microgram prolonged-release hard capsules</span></em>. <span property=\"bibo:Collection\">Electronic Medicines Compendium</span>. <span property=\"dc:publisher\">Datapharm Communications Ltd.</span> <span rel=\"bibo:Website\"><a href=\"https://www.medicines.org.uk/emc\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"9f4bd7b2-d4f8-430f-8be7-ac08000a177f\">https://www.medicines.org.uk/emc</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.medicines.org.uk/emc/product/9245/smpc\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"317e7506-b339-42c8-a772-ac08000a1790\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    ABPI                </span> (<span property=\"dcterms:issued\">2018b</span>) <em><span property=\"dc:title\">SPC for Hytrin Tablets 2mg</span></em>. <span property=\"bibo:Collection\">Electronic Medicines Compendium</span>. <span property=\"dc:publisher\">Datapharm Communications Ltd.</span> <span rel=\"bibo:Website\"><a href=\"https://www.medicines.org.uk/emc\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"b24975bc-3bb0-4e06-89f6-ac08000a193d\">https://www.medicines.org.uk/emc</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.medicines.org.uk/EMC/medicine/20231/SPC/Hytrin+Tablets+2mg\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"de0771f1-1cb5-4d19-a6d9-ac08000a194c\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    ABPI                </span> (<span property=\"dcterms:issued\">2018c</span>) <em><span property=\"dc:title\">SPC for Dutasteride 0.5 mg soft capsules</span></em>. <span property=\"bibo:Collection\">Electronic Medicines Compendium</span>. <span property=\"dc:publisher\">Datapharm Communications Ltd.</span> <span rel=\"bibo:Website\"><a href=\"https://www.medicines.org.uk/emc\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"68d1b172-dc07-49d6-8112-ac08000a1c0d\">https://www.medicines.org.uk/emc</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.medicines.org.uk/emc/product/9277/smpc\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"d5d467e0-287c-4e32-84b5-ac08000a1c21\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    ABPI                </span> (<span property=\"dcterms:issued\">2018d</span>) <em><span property=\"dc:title\">SPC for&#160;Finasteride 5mg Tablets</span></em>. <span property=\"bibo:Collection\">Electronic Medicines Compendium</span>. <span property=\"dc:publisher\">Datapharm Communications Ltd.</span> <span rel=\"bibo:Website\"><a href=\"https://www.medicines.org.uk/emc\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"ff7a6b03-04b0-451f-9b02-ac08000a19c6\">https://www.medicines.org.uk/emc</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.medicines.org.uk/emc/medicine/23066#CONTRAINDICATIONS\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"0e338a85-365c-4587-a088-ac08000a19d5\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    ABPI                </span> (<span property=\"dcterms:issued\">2019a</span>) <em><span property=\"dc:title\">SPC for&#160;CARDURA 1mg Tablets</span></em>. <span property=\"bibo:Collection\">Electronic Medicines Compendium</span>. <span property=\"dc:publisher\">Datapharm Communications Ltd.</span> <span rel=\"bibo:Website\"><a href=\"https://www.medicines.org.uk/emc\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"309ba4ea-229c-4dfe-88b8-ac080008d694\">https://www.medicines.org.uk/emc</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.medicines.org.uk/emc/product/1064/smpc\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"8b782c72-393d-44e6-a358-ac080008d6a3\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    ABPI                </span> (<span property=\"dcterms:issued\">2019b</span>) <em><span property=\"dc:title\">SPC for Cardura XL 4mg tablet</span></em>. <span property=\"bibo:Collection\">Electronic Medicines Compendium</span>. <span property=\"dc:publisher\">Datapharm Communications Ltd.</span> <span rel=\"bibo:Website\"><a href=\"http://www.medicines.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"d96c9630-927b-450d-b3fa-ac08000a1894\">http://www.medicines.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.medicines.org.uk/emc/product/1310/smpc\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"4bc4fa79-ced4-421a-bbfe-ac08000a18c2\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:editorList\">                    Aronson, J.K.                </span> (Eds.) (<span property=\"dcterms:issued\">2006</span>) <em><span property=\"dc:title\">Meyler&#39;s side effects of drugs. The international encyclopedia of adverse drug reactions and interactions</span></em>. 15th edn. Oxford:  <span property=\"dc:publisher\">Elsevier</span>.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    BNF                </span> (<span property=\"dcterms:issued\">2018</span>) <em><span property=\"dc:title\">British National Formulary</span></em>. 76th edn. London:  <span property=\"dc:publisher\">British Medical Association and Royal Pharmaceutical Society</span>.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Chapple, C., Herschorn, S., Abrams, P.,                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2009</span>) <span property=\"dc:title\">Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers</span>. <em>European Urology</em> <strong><span rel=\"bibo:volume\">56</span></strong>(<span rel=\"bibo:issue\">3</span>),  534-541. [<span rel=\"bibo:abstract\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19070418\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"d8895c18-5272-448d-ab05-ac0a000038f4\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    EAU                </span> (<span property=\"dcterms:issued\">2018</span>) <em><span property=\"dc:title\">Management of Non-neurogenic Male LUTS</span></em>. <span property=\"dc:publisher\">European Association of Urology</span>. <span rel=\"bibo:Website\"><a href=\"http://www.uroweb.org/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"2ce03cd4-8515-4562-8f1a-ac03008f1492\">http://www.uroweb.org</a></span> [<span rel=\"bibo:uri\"><a href=\"https://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/#3\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"38fedffa-77c3-408c-ac44-ac03008f14f3\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Han, J., Jung, J.H. and Bakker, C.J. et al.                </span> (<span property=\"dcterms:issued\">2017</span>) <em><span property=\"dc:title\">Desmopressin for treating nocturia in men (Cochrane Review/Cochrane Intervention Protocol)</span></em>. <span property=\"bibo:issue\">Issue 10</span>. <span property=\"dc:publisher\">John Wiley &amp; Sons, Ltd.</span> <span rel=\"bibo:Website\"><a href=\"http://www.cochranelibrary.com/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"2e4063a5-cd44-4849-a387-ac0200c0e95b\">http://www.cochranelibrary.com</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012059.pub2/full\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"43567248-bd66-4534-ab06-ac0200c0ea35\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Hunskaar, S., Burgio, K., Clark, A.,                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2005</span>) <em><span property=\"dc:title\">Epidemiology of urinary (UI) and faecal (FI) incontinence and pelvic organ prolapse (POP)</span></em>. <span property=\"bibo:Collection\">WHO-ICS International Consultation on Incontinence</span>. <span property=\"dc:publisher\">World Health Organization</span>. <span rel=\"bibo:Website\"><a href=\"http://www.icsoffice.org/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"0810f784-2a24-46d1-bb77-ac0500625019\">http://www.icsoffice.org</a></span> [<span rel=\"bibo:uri\"><a href=\"http://www.icsoffice.org/ASPNET_Membership/Membership/Publications/ICI_3/v1.pdf/chap5.pdf\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"fac38fbf-1743-4be0-8ec1-ac050062504c\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Kaplan, S.A., Roehrborn, C.G., Rovner, E.S.,                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2006</span>) <span property=\"dc:title\">Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial</span>. <em>JAMA</em> <strong><span rel=\"bibo:volume\">296</span></strong>(<span rel=\"bibo:issue\">19</span>),  2319-2328. [<span rel=\"bibo:abstract\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17105794\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"ce7c0c1a-fab0-4537-bb59-ac090175fe02\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Kaplan, S.A., Roehrborn, C.G., Chancellor, M.,                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2008</span>) <span property=\"dc:title\">Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score</span>. <em>BJU International</em> <strong><span rel=\"bibo:volume\">102</span></strong>(<span rel=\"bibo:issue\">9</span>),  1133-1139. [<span rel=\"bibo:abstract\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18510659\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"391740b7-efa3-4116-adde-ac090174a76f\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Maman, K., Aballea, S., Nazir, J.,                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2014</span>) <span property=\"dc:title\">Comparative efficacy and safety of medical treatments for the management of overactive bladder: a systematic literature review and mixed treatment comparison</span>. <em>European Urology</em> <strong><span rel=\"bibo:volume\">65</span></strong>(<span rel=\"bibo:issue\">4</span>),  755-765. [<span rel=\"bibo:abstract\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/24275310\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"62e5003e-f203-4221-a9eb-ac090150ab41\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    MHRA                </span> (<span property=\"dcterms:issued\">2009</span>) <em><span property=\"dc:title\">Additional hypotensive effects following co-administration of non-selective alpha-blockers and phosphodiesterase-5-inhibitors: guidance for marketing authorisation holders</span></em>. <span property=\"dc:publisher\">Medicines and Healthcare products Regulatory Agency</span>. <span rel=\"bibo:Website\"><a href=\"http://www.mhra.gov.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"6088d00f-0af4-4597-ad22-ac05006f9076\">http://www.mhra.gov.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"http://www.mhra.gov.uk/Howweregulate/Medicines/Medicinesregulatorynews/CON046605\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"f56d0229-9aa8-405c-8537-ac05006f9094\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    MHRA                </span> (<span property=\"dcterms:issued\">2017</span>) <em><span property=\"dc:title\">Finasteride: rare reports of depression and suicidal thoughts</span></em>. <span property=\"dc:publisher\">Medicines and Healthcare products Regulatory Agency</span>. <span rel=\"bibo:Website\"><a href=\"http://www.gov.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"616a0fb7-5bb0-44f0-bbcd-ac03007f3965\">http://www.gov.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.gov.uk/drug-safety-update/finasteride-rare-reports-of-depression-and-suicidal-thoughts\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"ec100054-2e7f-41b4-8110-ac03007f3975\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    National Clinical Guideline Centre                </span> (<span property=\"dcterms:issued\">2015</span>) <em><span property=\"dc:title\">The management of lower urinary tract symptoms in men&#160;(full NICE guideline)</span></em>. <span property=\"dc:publisher\">National Clinical Guideline Centre</span>. <span rel=\"bibo:Website\"><a href=\"http://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"ff8646e3-beb9-437a-8f8c-ac03008f0eb1\">http://www.nice.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.nice.org.uk/guidance/cg97/evidence/full-guideline-pdf-245363873\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"b6be5d6c-38c7-4faa-b5c2-ac03008f0ed9\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    National Collaborating Centre for Women&#39;s and Children&#39;s Health                </span> (<span property=\"dcterms:issued\">2013</span>) <em><span property=\"dc:title\">Urinary incontinence: the management of urinary incontinence in women (full guideline)</span></em>. <span property=\"dc:publisher\">National Collaborating Centre for Women&#39;s and Children&#39;s Health</span>. <span rel=\"bibo:Website\"><a href=\"http://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"48955fa9-de1c-4f80-945e-ac05005e1c1b\">http://www.nice.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"http://www.nice.org.uk/Guidance/CG171/Evidence\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"896069b5-6178-42ad-a8c6-ac05005e1c42\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2010</span>) <em><span property=\"dc:title\">The management of lower urinary tract symptoms in men (NICE guideline)</span></em>. <span property=\"dc:publisher\">National Institute for Health and Clinical Excellence</span>. <span rel=\"bibo:Website\"><a href=\"http://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"10b41981-fd83-45af-a014-ac05005d2784\">http://www.nice.org.uk</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2013a</span>) <em><span property=\"dc:title\">Lower urinary tract symptoms in men. Quality standard (QS45)</span></em>. <span property=\"dc:publisher\">National Institute for Health and Care Excellence</span>. <span rel=\"bibo:Website\"><a href=\"http://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"d57b72eb-fe38-45ad-9ea1-ac03008f15ce\">http://www.nice.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.nice.org.uk/guidance/qs45/chapter/List-of-quality-statements\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"41729a21-5ccc-4f05-af19-ac03008f15f3\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2013b</span>) <em><span property=\"dc:title\">Mirabegron for treating symptoms of overactive bladder (NICE technology appraisal 290)</span></em>. <span property=\"dc:publisher\">National Institute for Health and Clinical Excellence</span>. <span rel=\"bibo:Website\"><a href=\"http://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"a9ed720e-a8b2-449e-bc21-ac0300647f88\">http://www.nice.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.nice.org.uk/Guidance/TA290\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"aa692b4e-0c72-416e-be93-ac0300647fb0\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2015</span>) <em><span property=\"dc:title\">Lower urinary tract symptoms in men: management</span></em>. <span property=\"dc:publisher\">National Institute for Health and Care&#160;Excellence</span>. <span rel=\"bibo:Website\"><a href=\"http://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"3c1cd168-f6c8-41ec-8d4a-ac05007b5e41\">http://www.nice.org.uk</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Park, T. and Choi, J.                </span> (<span property=\"dcterms:issued\">2014</span>) <span property=\"dc:title\">Efficacy and safety of dutasteride for the treatment of symptomatic benign prostatic hyperplasia (BPH): a sustematc review and meta-analysis</span>. <em>World Journal of Urology</em> <strong><span rel=\"bibo:volume\">32</span></strong>(<span rel=\"bibo:issue\">4</span>),  1093-1105. [<span rel=\"bibo:abstract\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/24500194\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"9fcd96da-2e0b-4695-be89-ac0901789d7e\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Parsons, J.K.                </span> (<span property=\"dcterms:issued\">2010</span>) <span property=\"dc:title\">Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors</span>. <em>Current Bladder Dysfunction Report</em> <strong><span rel=\"bibo:volume\">5</span></strong>(<span rel=\"bibo:issue\">4</span>),  212-218. [<span rel=\"bibo:uri\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061630\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"f34e1030-b2e7-4cfe-9159-ac080009f379\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    PHE                </span> (<span property=\"dcterms:issued\">2016a</span>) <em><span property=\"dc:title\">Guidance. Prostate cancer risk management&#160;programme&#160;(PCRMP): benefits and risks of PSA testing</span></em>. <span property=\"dc:publisher\">Public Health England</span>. <span rel=\"bibo:Website\"><a href=\"http://www.gov.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"12f34e5e-a2b7-4d72-b3a2-ac03008f153b\">http://www.gov.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.gov.uk/government/publications/prostate-cancer-risk-management-programme-psa-test-benefits-and-risks/prostate-cancer-risk-management-programme-pcrmp-benefits-and-risks-of-psa-testing#the-psa-test\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"dfc91bd3-37bd-4d0c-b774-ac03008f154c\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    PHE                </span> (<span property=\"dcterms:issued\">2016b</span>) <em><span property=\"dc:title\">Advising well men aged 50 and over about the PSA test for prostate cancer: information for GPs</span></em>. <span property=\"dc:publisher\">Public Health England</span>. <span rel=\"bibo:Website\"><a href=\"http://www.gov.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"f30858ff-539a-4ff6-8b59-ac03008f1517\">http://www.gov.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/509193/Prostate_Summary_Sheet.pdf\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"c062d428-331e-43a8-95a1-ac03008f1528\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Reynard, J., Brewster, S. and Biers, S.                </span> (<span property=\"dcterms:issued\">2013</span>) <em><span property=\"dc:title\">Oxford handbook of urology</span></em>. Oxford:  <span property=\"dc:publisher\">Oxford University Press</span>.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Smellie, W.S., Forth, J., Coleman, J.J.,                        <em>et al.</em>                </span> <span property=\"dc:title\">Best practice in primary care pathology: review 6</span>. <em>Journal of Clinical Pathology</em> <strong><span rel=\"bibo:volume\">60</span></strong>(<span rel=\"bibo:issue\">3</span>),  225-234. [<span rel=\"bibo:abstract\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16822875\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"8598a0e5-641d-45a9-a88c-ac070171b1dc\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Tsakiris, P., Oelke, M. and Michel, M.C.                </span> (<span property=\"dcterms:issued\">2008</span>) <span property=\"dc:title\">Drug-induced urinary incontinence</span>. <em>Drugs &amp; Aging</em> <strong><span rel=\"bibo:volume\">25</span></strong>(<span rel=\"bibo:issue\">7</span>),  541-549. [<span rel=\"bibo:abstract\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18582143\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"87c55f8a-5220-43e6-bda2-ac0901852bdd\">Abstract</a></span>]            </span></li></ul><!-- end field e86ca9f6-b86b-44cc-a742-108eed866b57 --><!-- end item 92c0d8e4-4f3b-4954-a26c-316da3acad16 -->","topic":{"id":"fdcce69d-578e-5994-a7c2-84be40932dd8","topicId":"a7bf3f2d-1d9e-47c0-9dd3-26731c4d092b","topicName":"LUTS in men","slug":"luts-in-men","lastRevised":"Last revised in March 2019","chapters":[{"id":"149361eb-636f-59a5-a2e2-b067d629a065","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"c7972342-637c-56a9-8783-c1e8314e7fd1","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"7105be47-f38b-5335-b14d-69db43326579","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"c8165ab8-59af-557d-824d-58f09041698f","slug":"changes","fullItemName":"Changes"},{"id":"776566d2-009e-5ebd-ac21-e5605029213a","slug":"update","fullItemName":"Update"}]},{"id":"4c1332b1-3f4f-530f-bb70-d627804caa79","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"d434ba09-30c6-5bfc-bb6f-87e952a1b33a","slug":"goals","fullItemName":"Goals"},{"id":"702b01d3-71e8-5daf-a985-3935596391f5","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"0aef110d-14b4-5ae2-9da0-a07cc4aef9ef","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7fcf6ae7-162e-5b90-84fb-2a79f82d420e","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"1c91c138-4e44-571e-8ac0-8e62f8dca310","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"4fe99a13-4e80-5c28-b091-216c8a8d7f82","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"3a98397f-2bc4-5e01-90d6-03d6fbe400c8","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"d41a85e2-c1cb-5198-afc7-7c4fbe28ae24","slug":"definitions","fullItemName":"Definitions"},{"id":"fd0f4942-31d6-517a-a10b-d341e34a2504","slug":"causes-of-luts","fullItemName":"Causes of LUTS"},{"id":"3af3e2a4-26b3-5a77-9e8b-3d393388e624","slug":"prevalence","fullItemName":"Prevalence"},{"id":"1c6eecc6-b753-5918-adae-dc2d864d88fa","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"d1432aa0-7841-5eec-85c4-e344d4629bd9","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"762c13bd-ead4-5aa6-b460-701b0572f9aa","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"8874a841-31e1-5356-a3f6-7bff9c28c693","slug":"assessment","fullItemName":"Assessment"},{"id":"8c77fb91-6134-565b-b1ef-4452e83c424f","slug":"investigations","fullItemName":"Investigations"}]},{"id":"60ffa7b7-da40-599a-bffa-e6e68db76a97","fullItemName":"Management","slug":"management","subChapters":[{"id":"1d790431-a0c8-5ca1-8143-be639ea2ec02","slug":"voiding-symptoms","fullItemName":"Scenario: Voiding symptoms"},{"id":"b1451e1b-3776-5aa0-94b0-79be5fb01831","slug":"overactive-bladder","fullItemName":"Scenario: Overactive bladder"},{"id":"f4818005-dc3a-52b2-ac5d-d14f0d6ac0db","slug":"nocturnal-polyuria","fullItemName":"Scenario: Nocturnal polyuria"},{"id":"fb3acb54-4d76-5aad-ab1c-7b0b3d9443a3","slug":"stress-urinary-incontinence","fullItemName":"Scenario: Stress urinary incontinence"},{"id":"c511bb10-1198-548d-8e23-a1f6e98df926","slug":"urinary-retention","fullItemName":"Scenario: Urinary retention"},{"id":"0a3e83b8-a00f-520f-b21f-9ef6cc6440e7","slug":"post-micturition-dribble","fullItemName":"Scenario: Post-micturition dribble"}]},{"id":"40ed844e-b196-5a8a-9d88-2ff299e04d85","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"9c9f3458-4ae7-5003-a4f9-ed026a61a3d0","slug":"alpha-blockers","fullItemName":"Alpha-blockers"},{"id":"2f32bd76-64d1-51c9-bc96-4173829de1b5","slug":"5-alpha-reductase-inhibitors","fullItemName":"5-alpha reductase inhibitors"},{"id":"d7f3eec1-9124-5d3a-a793-15707f8cfeda","slug":"antimuscarinics","fullItemName":"Antimuscarinics"},{"id":"507e078b-b3d0-527c-b71d-0b1101948c01","slug":"mirabegron","fullItemName":"Mirabegron"},{"id":"7c2851da-6e40-5415-ada7-7466766510fa","slug":"furosemide","fullItemName":"Furosemide"},{"id":"ae12d520-87b4-5400-8cfa-79a25bb39663","slug":"desmopressin","fullItemName":"Desmopressin"}]},{"id":"dca797b5-427f-5ed5-94e4-3ad565f628a9","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"5e289c42-8089-5739-9683-20c374967578","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"07accac1-c375-54a3-92cc-d2cd8a2bb914","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"c05a5332-4c79-595e-b066-09dcd9841073","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"8e5cf2cc-d3d4-5d7d-82a7-3dd1ae3c65d9","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"47ea76bd-52d3-5c5a-8d1f-f574eec081bd","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"38a45d79-a74f-5ca9-a844-f16ea2c0ab75","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"0b3152db-f873-5814-b35f-54711f247dff","fullItemName":"References","slug":"references","subChapters":[]}]},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}